MENU
+Compare
HOOK
Stock ticker: NASDAQ
AS OF
Jun 20 closing price
Price
$1.29
Change
-$0.01 (-0.77%)
Capitalization
15.72M

HOOK HOOKIPA Pharma Inc. Forecast, Technical & Fundamental Analysis

HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system... Show more

HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HOOK with price predictions
Jun 20, 2025

Momentum Indicator for HOOK turns negative, indicating new downward trend

HOOK saw its Momentum Indicator move below the 0 level on June 10, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In of the 83 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for HOOK moved out of overbought territory on May 21, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for HOOK turned negative on May 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HOOK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

HOOK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 76 cases where HOOK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.461) is normal, around the industry mean (16.740). P/E Ratio (0.000) is within average values for comparable stocks, (59.155). HOOK's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.273). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (1.731) is also within normal values, averaging (254.620).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HOOK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HOOK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

HOOK is expected to report earnings to fall 91.46% to -10 cents per share on August 08

HOOKIPA Pharma Inc. HOOK Stock Earnings Reports
Q2'24
Est.
$-0.10
Q1'25
Missed
by $1.06
Q4'24
Missed
by $1.85
Q1'24
Beat
by $0.21
Q4'23
Missed
by $0.03
The last earnings report on May 15 showed earnings per share of -123 cents, missing the estimate of -17 cents. With 159.59K shares outstanding, the current market capitalization sits at 15.72M.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
350 Fifth Avenue, 72nd Floor
Phone
+1 431 890-6360
Employees
179
Web
https://www.hookipapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HBIO0.530.04
+9.00%
Harvard Bioscience
WLK72.010.83
+1.17%
Westlake Corp
TRIB0.57N/A
-0.77%
Trinity Biotech plc
WHD45.06-0.43
-0.95%
Cactus
SNDX9.48-0.21
-2.17%
Syndax Pharmaceuticals

HOOK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HOOK has been loosely correlated with QURE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HOOK jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOOK
1D Price
Change %
HOOK100%
-1.15%
QURE - HOOK
44%
Loosely correlated
-5.89%
MTVA - HOOK
44%
Loosely correlated
-3.41%
PYXS - HOOK
32%
Poorly correlated
+2.63%
MNMD - HOOK
30%
Poorly correlated
-0.56%
IGMS - HOOK
30%
Poorly correlated
N/A
More